Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-11 to 2025-03-26
Current total value of award: $278.19
Description: 8511240053!HEPATITIS B VIRUS V